importance and holds a promise for the possibility of using genetically targeted dietary interventions to reduce obesity risk in the future.
Introduction
Obesity is a medical condition in which excess body fat accumulates to the extent that it may have negative impacts on health [1] . Obesity is one of the largest health problems Abstract The prevalence of obesity is skyrocketing worldwide. The scientific evidence has associated obesity risk with many independent factors including the quality of dietary fat and genetics. Dietary fat exists as the main focus of dietary guidelines targeting obesity reduction. To prevent/minimize the adipogenic effect of dietary fatty acids (FA), intakes of long-chain saturated-and trans-FA should be reduced and substituted with unsaturated FA. The optimal proportions of dietary unsaturated FA are yet to be defined, along with a particular emphasis on the need to achieve a balanced ratio of n-3:n-6 polyunsaturated FA and to increase monounsaturated FA consumption at the expense of saturated FA. However, inter-individual variability in weight loss in response to a dietary intervention is evident, which highlights the importance of exploring gene-nutrient interactions that can further modulate the risk for obesity development. The quality of dietary fat was found to modulate obesity development by interacting with genes involved in fatty acid metabolism, adipogenesis, and the endocannabinoid system. This review summarizes the current knowledge on the effect of the quality of dietary fat on obesity phenotype and obesity-related genes. The evidence is not only supporting the modulatory effect of fat quality on obesity development but also presenting a number of interactions between obesity-related genes and the quality of dietary fat. The identified gene-FA interaction may have a clinical and its prevalence is skyrocketing worldwide [2] [3] [4] . Many dietary, environmental, metabolic, and genetic factors are likely involved in obesity development. Dietary fat is the most energy-dense macronutrient, therefore, its consumption may influence energy balance and consequently, body weight and fatness [5, 6] . Even though the quantity of dietary fat has an integral role in obesity development, the effect of the quality of dietary fat on body fat accumulation has been recognized by many researchers [6] [7] [8] [9] . Different fatty acids (FA) may vary in their obesity-inducing effect by directing the metabolism toward a pathway of either oxidation or storage [5, 10] , as well as by influencing satiety and appetite sensations [11, 12] . The consumption of long-chain saturated FA (SFA) and trans-FA has been linked to obesity and specifically to abdominal fat accumulation [6, 13] , while unsaturated FA, polyunsaturated FA (PUFA) and monounsaturated FA (MUFA), have been found to suppress appetite as well as increase energy expenditure and fat oxidation rate, therefore, induce favorable effects on regional and total fat mass, as compared to the former two types [7-10, 12, 14] .
Although excess body fat can mostly be modulated by controlling obesity-related environmental factors, genetic predisposition also plays an integral role in obesity development [15, 16] . The genetic contribution to obesity explains up to 84% of body mass index (BMI) [4] . Many genes have been implicated in obesity development by several genomewide association studies [17] [18] [19] . Indeed, currently, at least 190 gene loci have been found to be associated with general obesity and fat distribution [20] . Furthermore, epigenetic modifications which are defined as the heritable changes in gene expression that do not involve changes to the underlying DNA sequence, such as DNA methylation and histone modification, have been implicated in obesity development [21] [22] [23] . Epigenome-wide association study identified 278 methylation sites associated with BMI [24] . Although many genes are involved in the adipogenesis process, two main points remain to be elucidated; the influence of genetic variation on body weight changes and whether nutrients can modify the adipogenic effect of genes. It is therefore difficult to identify the main contributor to obesity development and fat distribution due to the complex interactions between environmental and genetic factors. However, the study of gene-diet interactions holds promise of the eventual development of a personalized prevention and treatment intervention. The study of gene-diet interactions can be divided into three main disciplines; nutrigenetics, nutrigenomics, and nutriepigenomics, which are, respectively, the science of the effect of genetic variation on dietary response, the science of the role of nutrients in gene expression via interaction with genetic structure, and the science of the role of nutrients on gene expression via epigenetic modifications [25] . The type of dietary fat has been reported to influence the function/ expression level of lipid metabolism and deposition-related genes, and therefore, modulate obesity risk [26, 27] . A diet high in SFA mostly upregulates the lipogenic genes; SFA and trans-FA consumption increase the activity of hepatic lipogenesis and the induction of de novo MUFA synthesis, therefore, elevating the risk of excessive fat deposition [28, 29] . In contrast, the consumption of unsaturated FA downregulates lipogenesis-related genes and upregulates FA oxidation-related genes, therefore, induces reductions in blood triglyceride and FA levels, fatty acid-cellular uptake, as well as the extent of fat deposition [28] . Here, we intend to contribute to the fast-growing evidence regarding the effect of dietary fat quality on obesity. Given the role of dietary FA in obesity development and as being one important focus of nutritional intervention targeting obesity reduction, the objective is to firstly overview the clinical trial-based evidence on the effect of dietary FA on adiposity. Secondly, an emerging evidence indicates a modulatory effect of dietary fat quality on the influence of genetic factors on fat deposition and distribution. Therefore, we identified and summarized the evidence concerning the interaction between the quality of dietary fat and adipogenesis/lipogenesis-related genes. To achieve the objective of this paper, we searched the PubMed database using different combinations of several keywords including terms "dietary fatty acids, level polyunsaturated fatty acid, level monounsaturated fatty acid, level saturated fatty acid, gene-expression, polymorphism, epigenetics, obesity, depot-specific, visceral, and subcutaneous".
Overview of the Effect of Dietary Fat on Development of Obesity Fat Quality and Body Composition
Hypocaloric diets or adjusting the amount of a specific macronutrient does not necessarily induce regional-specific fat mass reduction, however, regional fat mass shift might be induced by specific dietary component(s) [30] . The quality of dietary fat has been suggested to play a vital role in fat deposition and distribution [10, 31] , despite the controversy regarding the optimal type of dietary fat for obesity risk reduction. Until recently, the main dietary recommendation regarding the fat quality is to reduce the amount of SFA consumption and to increase unsaturated FA, which has been translated into higher intakes of omega-6 PUFA (n-6 PUFA), especially in a Western-type diet. In this section, we briefly review the clinical trial-based evidence.
Different dietary fats induce specific effects on body weight and fat mass [6, 7, 10] . For instance, long-chain SFA consumption has been shown to enhance body adiposity and to shift fat accumulation toward visceral depots [32, 33] , where it correlates with BMI, waist-to-hip ratio, and fat mass [34] [35] [36] . SFA consumption was found to have a significant direct correlation with fat cell size and number [37] . A 16-week high-fat diet (50% of total fat) supplemented with 9 g/day of stearate induced an increase in gynoid and total fat masses compared to energy-matched high-fat diet [38] . On the other hand, medium-chain triglyceride (MCT), SFA that contains 8-12 carbon atoms, has been suggested to increase energy expenditure, thermogenesis, fat oxidation, and satiety and to reduce fat accumulation in adipocytes [39] . Due to their smaller chain length, compared to long-chain FA, MCT-derived FA (MCFA) are more soluble and the majority can be absorbed rapidly with no need for esterification and incorporation into chylomicrons, therefore, swiftly metabolized for energy via β-oxidation in the liver [39, 40] . These differences in the absorption and metabolism make MCFA a fast energy source that may potentially result in a negative energy balance and weight loss [39] . Although the results are inconclusive regarding the effectiveness of MCT and the required dose to control body weight is not established yet, several long-and short-term studies showed an effect of MCT on increasing energy expenditure which therefore, might influence body weight and fat deposition [41] [42] [43] [44] [45] [46] [47] [48] . Evidence also indicates that MCT result in a regional fat shift in total, abdominal, and depot-specific adipose tissue as compared to long-chain FA [45] . In contrast, an accumulating evidence shows negative impacts of long-chain SFA on fat deposition [8, 10, 49] , nevertheless, some controversy remains over whether PUFA or MUFA induces the most favorable effect on fat mass [10, 50] . Also, the optimal amount of PUFA or MUFA that can be used to replace SFA has not yet been defined [10] .
There is still some discrepancy regarding the effectiveness of PUFA on weight loss and maintenance [49, 51] . In the early-in-life expansion of fat depots, hyperplasia and hypertrophy were found to be promoted by high n-6 PUFA consumption. This adipogenic effect was proven by in vitro, animal, and human studies [52] . However, as compared to SFA, dietary PUFA has been connected to a smaller, less pathogenic, adipocyte cell size in human [37] . Summers et al. reported a reduction in abdominal subcutaneous fat induced by the consumption of a high ratio of PUFA:SFA for 5 weeks, compared to a high SFA control diet, but no changes were detected in visceral adipose tissue (VAT), waist circumference (WC), or body weight [53] . It is worth mentioning that in this study, the SFA diet contained a significantly higher amount of MUFA compared to the PUFA rich diet which might have influenced the effect of the control diet on body weight and blunted the possible effect of PUFA rich diets on body weight and regional fat mass. Other studies showed negative associations between total PUFA consumption and PUFA:SFA ratio with VAT and total body fat percent [35, 54] . Some contradiction in the literature regarding the effect of dietary PUFA might have resulted from the differences in the proportions of n-3 and n-6 PUFA, between studies, especially given their suggested adipogenic differences. Adding omega-3 PUFA (n-3 PUFA) to a very low-calorie diet enhanced weight loss in obese women compared to very low-calorie diet [55], however, Munro and Garg have reported an absence of effect of adding n-3 PUFA on weight loss or weight maintenance to a very low-calorie diet [51] . Smaller doses might be of greater benefit as reported by Crochemore et al. where they found a significant reduction in body weight and WC following 30 days supplementation of 1.5 g/day of fish oil as compared to a higher dose of 2.5 g/day [56] . Additionally, conjugated linoleic acid has also been suggested to impose beneficial effects on body weight and body composition [57, 58] . The supplementation of conjugated linoleic acid (3 g/ day) and n-3 long-chain PUFA (3 g/day) for 12 weeks prevented abdominal fat deposition and increased fat-free mass and adiponectin levels, compared to a control supplementation consisting of 4.8 g palm oil and 1.2 g soybean oil [58] . Bjermo et al. reported that replacing SFA with n-6 PUFA promoted cardiovascular benefits but did not influence body weight [59] . Diets consisting of 10% of total energy of PUFA failed to provide any additional favorable effect on whole body weight, abdominal fat mass, or VAT mass as compared to a macronutrient-matched low-PUFA (5% of total energy) diet over a 12-week period, however, both diets induced significant reductions in body weight and fat mass [60, 61] . It is worth mentioning that the low-PUFA diet in this study had a higher MUFA content (15% of total energy compared to 10% in the PUFA enriched diet), therefore, the higher MUFA content might induce favorable effects on obesity indices and blunted the effect of the high PUFA diet.
MUFA consumption has been attracting particular recent scientific interest regarding its beneficial effects on disease and obesity risks [49, [62] [63] [64] [65] . Adherence to a diet rich in MUFA was not associated with obesity over the long term [66, 67] . Even though Garaulet et al. have found no association between MUFA consumption and fat cell size, however, the MUFA content of adipocytes has been found to be inversely related to fat cell number, which might indicate a preferential effect of MUFA in reducing hyperplasia [37] . Supplementing a high-fat diet with oleic acid (9 g/day) for 16 weeks induced a reduction in android fat mass as compared to a placebo high-fat diet (50% of total fat) [38] . No additional beneficial effects on body weight, WC, or total fat mass were detected following hypocaloric MUFA rich diet (22.5% MUFA, 11.25% PUFA, and 11.25% SFA) as compared to the hypocaloric diet with equal FA proportions (10% MUFA, 10% PUFA, and 10% SFA) in obese non-diabetic and type-2 diabetic individuals. However, this lack of effect might have be caused by diabetes-related changes in metabolism and/or lack of statistical power, as the authors indicated [68] . Nimptsch et al. found an inverse association between MUFA intake and prospective weight gain, while saturated and PUFA intakes were linearly associated with prospective weight gain [49] . Additionally, a MUFA-rich diet containing 23% of total energy was found to prevent further fat accumulation in abdominal region in abdominally obese subjects [30] . A randomized, cross-over, ad libitum feeding study found that a MUFA-rich diet (~23% MUFA 11% SFA of total energy) induced small but significant reductions in body weight and fat mass, as compared to a high SFA diet (~24% SFA and ~13% MUFA of total energy) [8] . The reductions in fat mass and body weight following the MUFA enriched diet were observed despite the lack of significant differences in the intake of energy or fat during the two diets [8] . Although Gillingham et al. reported lack of statistical differences in body weight and total and regional fat mass following diets rich in either SFA, higholeic canola oil, or flaxseed-high-oleic canola oil blend, this study found a trend toward significance (p = 0.055) in the ratio of android:gynoid fat mass [5] . The observed lower ratio of android:gynoid fat mass (mean ± SEM 1.11 ± 0.04) following the MUFA diet as compared to a diet rich in either SFA (1.12 ± 0.04) or PUFA (1.13 ± 0.04) might indicate a favorable effect of MUFA on body fat redistribution. Another trial was conducted to examine the effects of consumption of different dietary oils varying in their unsaturated fat contents on body composition and fat distribution in a randomized controlled crossover weight-maintenance full-feeding design [69] . This study has revealed favorable effects of MUFA-rich diets, including regular canola oil or high oleic canola oil, in terms of reducing body weight and android fat mass as compared to a diet rich in flax/safflower oil blend (PUFA-rich diet) [7] . Additionally, there is general agreement regarding the effectiveness of the Mediterranean diet, rich in α-linolenic acid and oleic acid, for weight and fat mass reduction/maintenance [64, 67, [70] [71] [72] [73] [74] . In summary, there is general agreement that substituting long-chain SFA with unsaturated FA induces beneficial effects on weight loss. While the evidence regarding the effect of PUFA consumption on obesity is showing a less clear conclusion, MUFA holds promise for effective dietary substitution for SFA.
Fat Quality and Energy Expenditure
Levels of energy expenditure and fat oxidation are important regulators of fat deposition. A decrease in the level of fat oxidation, especially in skeletal muscle; the main site for fat oxidation, can dramatically increase obesity risk [75, 76] . The fat oxidation rate is greatly influenced by insulin sensitivity which in turn might be affected by dietary fat quality. An animal trial showed that consumption of n-6 PUFA appeared to prevent insulin resistance compared to a diet rich in SFA [77] . In n-3 PUFA-fed rats, compared to lard (SFA)-fed rats PUFA increased lipid oxidation, enhanced the activation of AMP-activated protein kinase (AMPK; a key enzyme in cellular energy homeostasis), and improved insulin signaling in skeletal muscle [78] . Furthermore, oleic acid may contribute to the prevention of palmitate-induced insulin resistance by ameliorating palmitate-induced mitochondrial dysfunction in rat [79] . As compared to SFA consumption, consumption of MUFA [80, 81] and supplementation of long-chain n-3 PUFA [82, 83] were reported to improve insulin sensitivity in humans. The beneficial effects of unsaturated FA on insulin sensitivity and energy metabolism might be translated into a reduction in obesity risk.
Most of the existing evidence supports higher rates of whole body FA oxidation and diet-induced thermogenesis following unsaturated FA consumption compared to SFA consumption, however, data regarding the oxidative differences between PUFA and MUFA are less clear [10] . The lower oxidation rates of saturated compared to unsaturated FA reduce the energy expenditure level and increase their propensity to be stored in adipocytes [10, [84] [85] [86] . The data regarding PUFA effects on energy expenditure are less conclusive, especially because most studies that evaluated the effect of PUFA on energy expenditure have not specified the source of this fat, i.e. n-3 versus n-6, which would decrease the applicability of their results. An increasing body of evidence indicates increasing increments in fat oxidation rate, diet-induced thermogenesis, and energy expenditure with higher dietary MUFA levels [10, 14, [86] [87] [88] . In a recent randomized parallel-arm clinical trial, increased fat oxidation and reduced body fatness were observed in men who received 56 g/day of conventional or high-oleic peanuts for 4 weeks during an energy-restricted diet, as compared to a hypocaloric-control diet [9] . Even though Gillingham et al. have found that replacing SFA with high-oleic canola oil or flaxseed-high-oleic canola oil blend did not induce favorable effects on energy expenditure or fat oxidation, they reported a trend (p = 0.055) for increasing the ratio of android/gynoid fat mass following a high-oleic canola diet compared to a diet rich in flaxseed-high-oleic canola [5] . Piers et al. have reported a small but significant reduction in body weight following a 4-week MUFA-rich diet compared to an SFA-rich diet, however, no significant differences in energy expenditure or substrate oxidation rate were found between the two diets [8] . Furthermore, Kien and Bunn reported increases in FA oxidation in women and an elevation of energy expenditure in men following 28 days of high oleic acid-rich diet, as compared to a diet rich in palmitic acid [14] . Substituting dietary palmitic acid with oleic acid was associated with increased physical activity and resting energy expenditure [88] .
Moreover, in normal weight subjects, the majority of studies reported no short-term difference in fat oxidation following a high-fat meal enriched with MUFA, PUFA, or SFA [10, 87, 89] , while high PUFA and MUFA meals elevated the thermic effect of a meal compared to SFA [90] [91] [92] [93] . The contradiction on the effect of different dietary fats on rates of fat oxidation and energy expenditure might be due to the variations in study design or methodology between different trials. However, Krishnan and Cooper, have comprehensively reviewed the available evidence from the long-term intervention and postprandial meal challenge regarding the effect of different dietary FA in a high-fat diet/meal on substrate utilization, diet-induced thermogenesis, and fat oxidation. These authors report that unsaturated FA, especially MUFA, greatly increase diet-induced thermogenesis and fat oxidation as compared to SFA (MUFA ≥ PUFA ˃ SFA) [10] . The question remains whether or not the increased fat oxidation rate seen with MUFA consumption is sufficient to induce fat mass loss.
Fat Quality and Energy Consumption
The quality of dietary fat has been suggested to modulate energy consumption, the second arm of the energy balance equation, therefore, modulate obesity risk. Energy intake might be reduced when the ghrelin levels are reduced and peptide-YY, cholecystokinin, and glucagon-like peptide-1 levels are increased [11, 94] . A high-fat meal that is enriched with either PUFA or MUFA was found to suppress postprandial ghrelin levels in obese women to a significantly greater extent compared to a high-fat high-SFA meal, while a PUFA rich meal was able to significantly elevate peptide-YY compared to SFA and MUFA-rich meals in women with obesity [11] . However, these changes in satiety signals were not translated into shifts in the subjective appetite ratings (VAS) or changes in subsequent energy intake [11] . Also, Strik et al. did not support a specific role of SFA, MUFA, and PUFA on the subjective rating of hunger and fullness sensations as well as the subsequent food consumption over 6-h period [95] . Another study has reported an increase in cholecystokinin levels, a significant increase in fullness, and a reduction in hunger following PUFA and MUFA liquid meals in healthy subjects as compared to SFA meal [94] . Current evidence supports the effect of the degree of FA saturation on satiety subjective and physiological appetite responses [11, 90, 94] , however, it has yet to be elucidated whether MUFA or PUFA is most influential in controlling energy consumption [94, 96] . Anandamide, a FA neurotransmitter derived from the eicosatetraenoic acid and an essential n-6 polyunsaturated fatty acid, acts as an endogenous ligand for the cannabinoid receptor that stimulates appetite sensation which might increase energy consumption [12, 97] . Adequate consumption of long-chain n-3 PUFA and obtaining an n-6:n-3 PUFA ratio as close as possible to unity can blunt any possible adverse effects of arachidonic acid metabolites and hyperactivity of the cannabinoid system [98, 99] . Furthermore, the high oleic acid content of the diet was suggested to control appetite sensation and therefore, reduce energy intake by elevating post-prandial oleoylethanolamide level, which itself regulates food intake by influencing metabolic and reward systems [12, 97, 100] . This finding is novel in humans and might hold promise for using oils rich in oleic acid to control energy intake [12] . Taking the above-mentioned evidence, different dietary FA differently impact body composition, energy expenditure, and energy consumption, therefore, influence obesity risk in unalike ways. In summary, the optimal diet for weight reduction/maintenance has to be balanced in n-6:n-3 ratio, as close as possible to unity, and enriched in MUFA at the expense of long-chain SFA.
Nutrition is one of the most important factors that modulates the influence of genes on obesity risk. The aim of studying gene-nutrient interactions is to ultimately use genetic profile to personalize dietary recommendation. Given the effect of dietary fat quality on obesity, the next section summarizes the evidence concerning the effect of fat quality on lipogenesis/adipogenesis-related genes.
The Effect of Dietary Fat on Adipogenesis-Related Genes
As noted earlier, gene-nutrient interactions may eventually help to prevent/control obesity in high-risk individuals by designing personalized nutritional strategies. Dietary FA have been found to modulate the expression levels of several genes and transcriptional factors that are involved in cellular responsiveness to metabolic signals and/or the regulation of lipid and energy metabolism [28, 30] . The effects of dietary FA on obesity might depend on their chain length and desaturation degree. The two transcription factors, sterol regulatory element binding protein-1 (SREBP1) and peroxisome proliferator activated receptor (PPAR), have emerged as key mediators of gene regulation by dietary FA, therefore, the literature has mainly focused on the interaction of FA with these two transcriptional factors. Three main mechanisms underlie the gene-FA interaction; dietary influences on membrane FA composition, transcriptional regulation, and post-transcriptional processes [101] . Epigenetics (non-DNA sequence-related heritable changes) and genetics (DNA sequence-related heritable changes) may interact to modify the expression of genes, thereby, the risk for obesity and associated disease.
Obesity-Related Transcriptional Factors
Of the obesity-related genes that have been identified, two main transcriptional factors, PPAR and SREBP1 exist as key mediators of the effect of hormones and nutrients on the expression of fat accumulation-related genes [102] . Figure 1 displays the effects of these two transcriptional factors on adipogenesis and lipogenesis processes in adipose tissue and liver.
PPAR are transcriptional factors expressed mainly in skeletal muscle, liver, and brown adipose tissue which regulate the expression levels of several genes. PPAR are involved in the regulation of cellular differentiation, development, and the metabolism of lipid, protein, and carbohydrate [28, 103] . Three types of PPAR have been identified; beta (PPARδ), alpha (PPARα), and gamma (PPARγ) [103, 104] . Little is known about the role of PPARδ in lipid metabolism, however, the activation of adipocyte PPARδ might be involved in obesity risk reduction by enhancing the expression of FA oxidation-and utilization-related genes [105] . The activation of PPARα enhances FA oxidation pathways, increases energy expenditure, reduces de novo synthesis of FA in the liver and adipose tissue, and promotes thermogenesis in brown adipose tissue, therefore, reducing the level of fat deposition [28, [106] [107] [108] . PPARα activity is downregulated by insulin signals and enhanced by high free FA levels. PPARγ, expressed mainly in white and brown adipose tissue, is involved in adipocyte differentiation, and regulates the metabolic and endocrine functions of adipose tissue [28, 109] . In contrast to PPARα, PPARγ activation promotes the expression levels of lipogenesis-and adipogenesis-related genes yet ameliorate whole body insulin resistance and hypertriglyceridemia [28, [109] [110] [111] [112] . PPARγ is part of the adipocyte differentiation program and its activity is induced by higher levels of insulin, SREBP1, and FA [113] . PPARγ has been identified as a regulator of the levels of leptin, resistin, and adiponectin, modulating adipokines levels reflects an important role of PPARγ as a determinant of dietary intake, energy homeostasis, and obesity risk [104, 112] . The effect of PPARγ on adiposity levels has been verified by the strong positive relationships between the expression levels of PPARγ and several lipogenic enzymes as well as VAT adiponectin levels [31] . Therefore, PPAR influence obesity risk differently; the activation of PPARδ and PPARα reduces obesity risk by increasing energy expenditure and Fig. 1 The effect of peroxisome proliferator-activated receptor alpha (PPARα), gamma (PPARγ), and delta (PPARδ) and sterol regulatory element-binding proteins-1c (SREBP1c) on adipogenesis and lipogenesis processes in adipose tissue and liver fat oxidation, in contrast, PPARγ induces lipogenesis and adipogenesis and augments obesity risk.
SREBP are membrane-bound transcriptional factors that are involved in the uptake and biosynthesis of FA and triglyceride (SREBP1) as well as cholesterol (SREBP2) [114] . Insulin is an important regulator of SREBP transcriptional and protein levels, also insulin-induced activation of several lipogenesis genes requires upregulation of the expression levels of SREBP1 [28, 115] . Therefore, the induction of SREBP1 and PPARγ activities increases the lipogenesis and adipogenesis of triglyceride in adipose tissue by augmenting the expression of several adipogenic and lipogenic enzymes [28, 31] .
The Role of Saturated Fatty Acid on the Expression of Obesity-Related Genes
The effects of SFA on the expression of adipogenesis and lipogenesis-related genes were found to be modulated by the FA chain length. Short-chain FA consumption reduced the PPAR-induced activation of some hepatic lipogenic genes which might reduce the obesity risk [28] . Adipose tissue-MCFA have shown an ability to downregulate the expression levels of PPARγ and its downstream metabolic target genes as well as to improve insulin sensitivity and reduce lipoprotein lipase activity in adipocyte [40] . On the other hand, long-chain SFA consumption has been reported to upregulate the activity of SREBP1c and PPARγ which activates the lipogenic genes including stearoyl-CoA desaturase, fatty acid synthase, and acetyl-CoA carboxylase [26, 29] . Furthermore, the expression levels of PPARγ-and PPARγ-induced activation of adipogenic and lipogenic genes have been enhanced by a diet rich in trans-FA [28] . SFA is suggested to modulate gene expression by changing the cellular membrane composition which will change the intra-cellular substrate-to-product ratio of a target gene and therefore, will enhance/prevent its expression levels. For instance, SFA can mediate its effect on SREBP1 by changing the cellular membrane composition to possess more SFA which would decrease cholesterol and SFA levels in the endoplasmic reticulum, and therefore, increases SREBP1 maturation [28] . An animal trial presented a suggested mechanism by which the quality of dietary fat might modulate abdominal obesity; compared to SFA, the expression levels of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and CCAAT-enhancer binding protein-α (C/EBP-α) in retroperitoneal fat depot were higher following trans-FA and lower following PUFA consumption [116] . 11β-HSD-1 converts inactive corticosteroids into potent glucocorticoids, expressed in various tissues including liver and adipose tissue. Its expression is regulated by C/EBP-α, and the higher activity of this enzyme is associated with an increased VAT mass [109, 116] . The amplification of glucocorticoids action by SFA and trans-FA as compared to PUFA may increase fat deposition and insulin resistance and may, partly, explain the adipogenic and pathogenic effect of SFA and trans-FA [116] .
The Role of Unsaturated Fatty Acid on the Expression of Obesity-Related Genes
Unsaturated FA suppress expression levels of FA biosynthesis-related genes and upregulate FA oxidation-related gene expression levels. PUFA consumption, in general, has been found to induce activation of PPARα and several genes related to lipid oxidation and thermogenesis, resulting in an increased FA oxidation rate and a reduced risk of adipogenesis [28, 117, 118] . PUFA consumption has been found to suppress expression levels of many lipogenic genes and chiefly reduce the expression level of SREBP1 by either inhibiting mRNA gene expression or obstructing the proteolytic processing of SREBP1 precursor [26, 113, 117, 119] . PUFA consumption induces an opposite effect of SFA consumption on SREBP1 expression by the same mechanism reported earlier [28] . These 2 types of dietary PUFA induce different effects on fat metabolism and deposition; n-6 PUFA is suggested to promote fat deposition, while n-3 might induce the reverse effect. N-3 PUFA consumption was found to be associated with a reduction in PPARγ expression level and has been reported to suppress de novo lipogenesis [106, 120] . In contrast, n-6 PUFA have been reported to induce early activation of PPARγ and are recognized for having higher PPARγ-affinity as compared to other FA [121] . SREBP1c expression level was reported to be related directly to adipose tissue content of n-6 PUFA, while n-3 (α-linoleic acid) PUFA was found to blunt the lipogenic effects of n-6 PUFA by reducing expression levels of SREBP1c and fatty acid synthase in adipose tissue in rats [31] . Dietary n-3 PUFA was found to inhibit expression and nuclear transcription of SREBP1 therefore, reducing lipogenesis [106] . Such possible adipogenic effects of n-6 PUFA are suggested to be manifested when the ratio of n-6:n-3 PUFA is larger than unity, which is clearly demonstrated in a typical Western diet [31, 122] . A high dose of n-3 PUFA is required to blunt the adipogenic effect of n-6 PUFA [31, 123] , the optimal n-6:n-3 PUFA ratio can be best achieved by supplementing n-3 PUFA and reducing dietary n-6 PUFA consumption in a diet. The favorable effects of n-3 PUFA are suggested to be induced by changing the n-6:n-3 PUFA ratio of cellular membrane and plasma phospholipid contents which might alter the enzymatic activity and metabolic pathways, as well as by reducing the cellularity of adipose tissue and inhibiting hyperplasia and hypertrophy of adipocytes [123, 124] . Additionally, the beneficial effects of a balanced n-6:n-3 PUFA ratio might also be explained by an anti-inflammatory effect of n-3 PUFA which would ameliorate inflammatory status and enhance insulin sensitivity, and therefore, modulate adipogenesis and lipogenesis [31, 99] . Downregulation of the expression level of adiponectin gene was found to be induced by dietary enrichment with soybean high in n-6 PUFA, coconut high in MCFA, and lard high in LC-SFA, as compared to fish oil [125] , which might partly emphasize the superiority of n-3 PUFA in improving insulin sensitivity. Improving insulin sensitivity can modulate energy and lipid metabolism.
Little has been reported on the effect of MUFA on expression levels of adipogenic/lipogenic genes. Dietary MUFA upregulate the expression level of mitochondrial uncoupling protein-2 as well as PPARγ and its target genes which might alter energy balance, insulin resistivity, and adiposity level [118, 126] . However, MUFA consumption failed to suppress lipogenesis or to modulate PPARα activity as compared to a high n-3 PUFA diet in rats [106] . On the other hand, MUFA consumption in an isocaloric diet was found to prevent the reduction in postprandial adiponectin gene expression levels in peripheral tissue, improve insulin resistance, and induce preferential body fat distribution i.e., lower central deposition, compared to high carbohydrate diet in insulin resistance subjects [30] . Given the above-mentioned evidence from the clinical trials regarding the beneficial effects of dietary MUFA on obesity, further research on the effect of MUFA consumption on the expression levels of adipogenesis/lipogenesis-related genes is warranted to understand the underlying mechanism behind the favorable effects of MUFA.
Fat Quality and Epigenetic Modifications of Obesity-Related Genes
Evidence regarding the role of dietary FA on epigenetic regulations of the expression levels of obesity-related genes is scarce [127] . However, a few studies have demonstrated the epigenetic effects of FA consumption, especially PUFA, on obesity control and prevention mostly in animal models and cultured cells [22, [127] [128] [129] . The methylation of several obesity-related genes was found to be influenced by the proportions of PUFA:SFA, MUFA:SFA, and unsaturated fatty acid:SFA, indicating a role of epigenetics in the physiological responses to the quality of dietary fat [130] . Palmitate treatment in human islets demonstrated changes in DNA methylation and gene expression of 67 BMI-related genes [131] . Additionally, in cultured cells, arachidonic acid, palmitic acid, and oleic acid altered the DNA methylation of several genes that regulate pathological processes including obesity; arachidonic acid and palmitic acid induced similar DNA methylation profile compared to oleic acid-induced profile [132] . In a 7-week parallel controlled clinical trial in 31 healthy normal-weight adults [133] , overfeeding of SFA changed the methylation in the promoter regions of 125 genes and significantly altered the expression of 28 genes including acyl-CoA oxidase-1 in subcutaneous adipose tissue. In the same trial, PUFA altered the methylation in the promoter regions of 1797 genes including fat mass and obesity-associated gene (FTO) but did not significantly affect gene expression levels. The epigenetic targets, DNA methylation and histone modifications, were found to be involved in n-3 PUFA-induced modification of leptin expression in the adipose tissue of diet-induced obese mice [134] . Nutritional epigenomics is an emerging field of research and since dietary fat quality is a main contributor to obesity development, rigorous clinical trials are needed to directly assess the effect of FA on epigenetic modifications of obesity-related genes.
The Interaction Between Fat Quality and Single Nucleotide Polymorphisms of Obesity-Related Genes
Finally, dietary FA have been found to modulate the association between body composition and many genetic variants of obesity-related genes [111, [135] [136] [137] [138] [139] [140] [141] , Table 1 summarizes available evidence on dietary fatty acid-adipogenic gene interactions. The data show promising evidence of interactions between dietary FA and several polymorphisms located in genes that can co-ordinate the adipogenesis process either via a metabolically-evident pathway such as PPARγ or via a suggested mechanism such as Circadian Locomotor Output Cycles Kaput. However, many factors might modulate the interactions between dietary FA and genes, including ethnicity and many environmental factors, therefore, large-scale ethnic-specific longitudinal studies that account for many environmental, behavioral, and cultural variables are still required in order to eliminate as much as possible the confounders that might affect gene-nutrient interactions. The long-term aim for studying the gene-nutrient interaction is to instruct genotype-specific personalized dietary recommendations for the prevention and treatment of obesity. To achieve this goal, more randomized well-controlled clinical trials are needed to validate gene-nutrient interactions.
Abdominal Fat Depots Vary in Their Adipogenic Effect
Quantifying of total and regional fat mass as well as differentiating between the types of fat depots provide a clear picture regarding the pathogenesis of obesity and therefore, better insight to disease risk [142] . Subcutaneous adipose tissue (SCAT) is the adipocyte that lies just beneath the skin, while adipocyte that accumulates around the vital organ in the abdominal cavity is known as VAT. Studies have shown strong and independent associations between VAT depot, rather than SCAT, with metabolic abnormalities and chronic disease risks [143] [144] [145] [146] [147] . Anatomical, cellular, molecular, physiological and clinical differences exist between VAT and Carriers of rs9939609 AA allele or rs1121980 TT allele had a higher BMI than the other genotypes only when they had a high SFA intake [163] 776 Spanish women and men/a randomized trial
No interaction between the nutritional intervention and the polymorphism was found [164] 233 Spanish obese subjects men and women/a randomized trial
Lower levels of BMI, weight and fat mass were detected after a PUFA diet in A allele carriers than TT genotype subjects Compared to A allele carriers, a low PUFA intake in men with the GG was associated with a higher BMI, and higher waist and hip circumferences Compared to A allele carriers, a lower BMI was associated with a high PUFA intake in women with GG Compared to A allele carriers, a lower BMI and hip circumference were associated with a high SFA intake in women with the GG [171] 2212 white women and men/analysis of two independent study
Consuming a higher amount of MUFA in the Mediterranean population was associated with a higher BMI in major GG allele carriers [172] 1754 French men and women/survey STAT3 p /rs8069645, rs744166, rs2306580, rs2293152, rs10530050 A high SFA consumption in individuals carrying ≥2 risk alleles was associated with an increased risk of abdominal obesity compared with those carrying ≤1 risk alleles [173] 268 Normal-weight and obese, black and white women in South African
In white women only, a higher n-3 PUFA intake and a reduced n-6:n-3 PUFA ratio were associated with a lower BMI in carriers of rs1800795 C allele, rs1554606 T allele and rs2069845 AG genotype An increased SFA intake in A carriers was associated with a higher adiposity increase as compared to GG An increased MUFA intake in A carriers was associated with a higher weight as compared to GG [176] 223 Black South African obese and normal weight women/survey
No gene-nutrient interaction was found in any dietary fatty acid with this SNP on obesity [101] 308 European normal and obese, men and women/prospective survey
Interactions of high intakes of linoleic acid and arachidonic acid and A allele carriers showed a higher obesity risk [177] 261 Spanish obese men and women/survey
No significant differences on weight, BMI, WC, or fat mass in either genotype group with both diets [178] 936 European origin men and women/survey
The deleterious association of the A allele with obesity was observed in subjects with a low n-6 PUFA intake [165] 200 Mexican normal-weight and obese men and women/ survey APOA5 t /rs662799 and rs3135506 Carriers of rs3135506 GG genotype with a high SFA consumption had an increased risk of obesity.
[179] 2280 non-Hispanic whites men and women/survey APOA5 t /rs662799 and rs3135506 Rs662799 C minor allele carriers with the high MUFA intake had a lower obesity risk compared with TT carriers [180] 3462 Whites and Hispanic men and women/follow-up survey APOA2 u /rs5082 CC genotype with a high SFA intake was associated with a higher obesity prevalence [181] 2071 Puerto Ricans origin and Northern European ancestry men and women/survey
CC carriers who consumed a greater amount of SFA from a high-fat dairy foods had a greater BMI than those who consume less dairy fat [182] 737 Iranian diabetic patients men and women/survey
Carriers of CC allele with a high SFA intake had higher BMI [165] 200 Mexican normal-weight and obese men and women/ survey APOA2 u /rs3813627 and rs5082 No interaction was found between SFA intake and APOA2 SNP [183] 1225 Spanish overweight and obese men and women/ survey APOA2 u /rs5082 A high SFA intake was associated with a greater WC in minor allele homozygotes CC compared with non-minor allele carriers [184] 4602 Asian and Mediterranean obese men and women/ survey
In both populations, the CC genotype was associated with a greater degree of obesity in those consuming a high SFA diet [185] 700 Iranian diabetic men and women/cross-sectional APOB v /Ins/Del SNP within the first exon A high n-3 PUFA consumption decreased the obesity risk in carriers of the Del allele of APOB gene [186] 920 Puerto Rican origin men and women/survey LRP1 w /rs1799986, rs715948, and rs1800191 A high intake of SFA was associated with a higher BMI, and higher waist and hip circumferences in carriers of rs1799986 T allele compared to CC. High palmitic and stearic acids induced the strongest effect on BMI 
LRP1
mediates lipoprotein remnant uptake, is highly expressed in adipocyte, and has been suggested to play a role in adipogenesis, cell signaling, and energy and glucose metabolism SCAT [143, 148] . These variations between SCAT and VAT might influence their responsiveness to nutritional intervention. For instance, a systematic review showed a dissimilar responsiveness of VAT and SCAT to weight loss energyrestricted diet [149] . Depot-specific variations were also detected in mRNA expression levels and in the activity of several fat metabolism-related genes and transcriptional factors. Compared to VAT, higher activation levels of PPARγ and several downstream genes have been detected in SCAT [110, 150] , in contrast, the expression of PPARα in VAT has been reported to be higher than SCAT [151] . These two properties might reflect biological defense mechanism against visceral obesity by directing fat deposition from VAT to SCAT. On the other hand, PPARγ expression was found to be elevated in VAT of obese subjects as compared to non-obese subjects, which indicating obesity-induced metabolic changes that might be involved in directing fat deposition toward the pathological fat depot [152] . Guiu-Jurado et al. have reported a significant inverse association between BMI and two lipogenic genes (fatty acid synthase and Acetyl-CoA Carboxylase-1) as well as with PPARα in SCAT, while expression levels of these genes remained similar in VAT regardless of the degree of obesity [153] . Furthermore, the level of hormone-sensitive lipase in SCAT was found to be twofold lower than corresponding levels in VAT, explaining the elevated level of lipolysis in VAT of obese women [154] . The expression level of apolipoprotein-E, which plays an important role in lipid metabolism and modulate adipocyte substrate metabolism and storage, was found to be lower in VAT as compared to SCAT [155] . Also, a depot-specific difference in perilipin levels was suggested to contribute to differences in basal lipolysis and adipocyte size; levels of perilipin were found to be higher in VAT as compared to SCAT in women [154] . Additionally, nesfatin-1, an anorexigenic peptide, has been found to be secreted in a depot-specific manner, preferentially by SCAT [156] . No data are available regarding the effect of adipocyte-produced nesfatin-1 on energy homeostasis yet, however, this might reflect a favorable role of SCAT over VAT. Therefore, the detected depot-specific variation in expression levels of adipokines as well as adipogenic/ lipogenic genes might contribute to the variation in the adipogenic and pathogenic capacity of VAT.
Despite the well-established variations in the health risk posed by VAT versus SCAT, little is known about the effects of different dietary treatments on each depot. However, compared to SFA and MUFA dietary mixture, dietary docosahexaenoic acid has significantly reduced mRNA fatty acid synthase, hormone sensitive lipase, lipoprotein lipase, and leptin in VAT in rats, however, the expression levels of these enzymes in SCAT were not affected by n-3 PUFA [157] . A direct association was found between n-6 PUFA concentrations and SREBP1c expression levels in both fat depots, however, the responsiveness degree was higher in VAT than SCAT [31] .
Additionally, the FA composition of adipocytes is suggested to reflect FA composition over a long period [150] . SCAT and VAT have shown variations in their FA contents which may indicate variations in the pathological capacities of different FA. The degree of obesity, central obesity, and visceral fat were negatively associated with MUFA and n-3 PUFA content in visceral region [32] . Also, MUFA were found to contribute to the highest proportion of SCAT region as compared to its proportion in VAT [32, 150] . On the other hand, a positive association was found between n-6 PUFA content in adipose tissue and central obesity, and no difference in PUFA content has been found between SCAT and VAT [32] . Sabin et al. reported that palmitic acid induced significantly higher lipid accumulation in VAT as compared to oleate, in contrast, the latter was associated with fat deposition in SCAT [33] . Dietary PUFA perfectly mirrored their content in adipose tissue, particularly SCAT [1, 150, 157] , however, MUFA and SFA contents in adipocyte might not mirror their abundance in the diet because of the endogenous synthesis of these FA [1, 150] . In this regard, the SFA content in adipocyte imposes some controversy; Garaulet et al. reported a depot-specific variation in SFA contents of obese adult subjects, where SFA was significantly higher in the perivisceral region [32] . In contrast, Caron-Jobin et al. presented a negative correlation between BMI in obese women and the adipocyte stearic acid content, which is the most abundant SFA in Western diet and can be also synthesized endogenously [150] . This latter finding can be explained by an increased level of de novo synthesis of unsaturated FA from dietary SFA, especially given the finding that the increased desaturation level in SCAT is associated with overall obesity and with higher levels of stearoyl-CoA desaturase mRNA expression and protein abundance [150] . Therefore, the quality of dietary fat can even modulate the distribution of body fat and further affect obesity level and consequences.
Evidence suggests that the quality of fat determines the risk of fat deposition and fat distribution. This effect is directed, partly, by modulating the expression levels of adipogenic and lipogenic genes, via genetic and epigenetic modifications, as well as by the interaction with many genetic variants. However, more clinical trials are needed to validate the interactions between FA and adipogenesisrelated genes. The current clinical trial-based evidence support the beneficial effects of the increased consumption of dietary unsaturated fatty acids, especially MUFA, at the expense of SFA on weight loss/maintenance. The identified interactions between obesity-related genes and the quality of dietary fat may eventually lead to the use of genetic profile for tailoring nutritional intervention provided to individuals or population sub-group. 
